Advertisement

Topics

Search Results for "Equine Leukemia Prognosis"

20:53 EST 24th November 2017 | BioPortfolio

Matching Channels

Acute Leukemia

Acute leukemia occurs when a hematopoietic stem cell undergoes malignant transformation into a primitive, undifferentiated cell with abnormal longevity. These lymphocytes (acute lymphocytic leukemia...

Chronic Leukemia

Chronic leukemia is a long term increase of abnormal white blood cells. It can be classed as myelogenous or lymphocytic leukemia. For more information see the Leukemia pages Add the Leukemia New...

Chronic Lymphocytic Leukemia CLL

Chronic lymphocytic leukemia is a disease in which mature lymphocytes become cancerous and gradually replace normal cells in lymph nodes. CLL mainly affects elderly males in North America and Europe...

Acute Myelocytic Leukemia AML

Acute myelocytic leukemia is a life-threatening disease in which the neutrophil, basophil, eosinophil, and monocyte precursors become cancerous and rapidly replace normal cells in the bone marrow. ...

Acute Lymphocytic Leukemia ALL

Acute lymphocytic leukemia (ALL) is a life-threatening disease in which the cells that normally develop into lymphocytes become cancerous and rapidly replace normal cells in the bone marrow. ALL acc...

Matching News

Prognosis communication may be helpful to older adults with disabilities

Prognosis is the term for the most likely outcome of a medical condition. When it comes to health care, talking about your prognosis can be difficult for you, your family/friends, and even your health...

FDA Approves Vyxeos (daunorubicin and cytarabine) Liposome for Injection for Certain Types of Poor-Prognosis Acute Myeloid Leukemia

August 3, 2017 -- The U.S. Food and Drug Administration today approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML) or...

People with leukemia and their oncologists have vastly different perceptions of prognosis

(American Society of Clinical Oncology) A study of 100 people with acute myeloid leukemia (AML) receiving chemotherapy found that patient and physician perceptions of treatment risk and the likelihood...

Mosquitoes found with Eastern equine encephalitis virus – Huron Daily Tribune

Mosquitoes found with Eastern equine encephalitis virusHuron Daily TribunePROVIDENCE, R.I. (AP) — Rhode Island officials say the first mosquitoes of the year have tested positive for Eastern equine ...

Jazz’s Vyxeos Receives FDA Approval for Treatment of Certain Poor Prognosis Acute Myeloid Leukemia

DUBLIN, Aug. 3, 2017 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has approved Vyxeos™ (daunorubicin and cytarabine) ...

FDA Approves Inotuzumab Ozogamicin (Besponsa) for ALL

The new drug is for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). These patients have a very poor prognosis. FDA Approvals

Vyxeos Liposome for Injection Okayed for Patients with Two Types of AML

NewsVyxeos represents the first new chemotherapy advance in more than 40 years for adults with certain types of poor-prognosis acute myeloid leukemia.

Talking to older adults about health prognosis may be helpful

(American Geriatrics Society) In a new study published in the Journal of the American Geriatrics Society, researchers examined how older adults with disabilities later in life might react to learning ...

Matching PubMed Articles

The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia.

Acute myelogenous leukemia (AML) is a clinically heterogeneous disease that is frequently associated with relapse and a poor prognosis. Among the various subtypes, AML with the monosomal karyotype (AM...

High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.

Overexpression of CD200, a trans-membrane protein belonging to the immunoglobulin superfamily, has been associated with poor prognosis in patients with acute myeloid leukemia (AML). As few data are av...

Equine disease surveillance: quarterly summary.

This quarterly equine disease surveillance report, prepared by Defra, the Animal Health Trust and the British Equine Veterinary Association, covers: Summary of surveillance testing, January to March 2...

Non-seminomatous mediastinal germ cell tumor and acute megakaryoblastic leukemia.

The association between mediastinal germ cell tumors (MGCT) and acute megakaryoblastic (M7) leukemia has been known for many years. We hereby present this review to better characterize the coexistence...

DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia.

The Hypermethylation of Ras association domain family (RASSF) often plays a key role in malignant progression of solid tumors; however, their impact on the prognosis and survival of adult ALL patients...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement